Sundari R Pisupati
Founder Partner
EDUCATION
- LL.M., Columbia Law School (1998)
- B.A., LL.B. (Hons.) NLSIU Bangalore (1993)
PRACTICE FOCUS
- Mergers and Acquisitions
- Venture Capital/ Private Equity Investments
- Cross-border Transactions
- Joint Ventures
- Corporate Litigation
PROFILE
Sundari has over 29 years of experience as a lawyer both in India and the U.S. She has handled a variety of large investments, M&A and corporate/ commercial transactions involving domestic and International clients. She is a licensed attorney in India and New York.
She advises companies in various industry verticals such as information technology, financial services, infrastructure, biotechnology, healthcare, e-commerce, and pharmaceuticals among others, and represents domestic and international angel funds and venture capital funds.
Her practice focus primarily includes advising clients on domestic and cross-border business ventures, venture capital and private equity investments, and mergers and acquisitions. She has extensive experience in corporate law, advising on raising capital, complex commercial contracts, business collaborations, and joint ventures among others. She also handles advises regularly on commercial and corporate litigation matters.
She earlier worked at Sidley Austin LLP, a law firm at Manhattan, New York for several years in the corporate and securities group.
She is regularly invited to national and international events to speak on various topics of current legal interest.
REPRESENTATIVE TRANSACTIONS
- Represented Brightcom Group Limited in its acquisition of Vuchi Media Private Limited for a total consideration of INR 566,00,00,000 (~USD 75 million).
- Represented Accolite Digital in the sale of its majority stake to New Mountain Capital for ~USD 250 million.
- Represented Syniti DMR LLC on the India leg of its global merger with Intermediate Holdings Inc.
- Represented IFFCO (UAE) on its 100% acquisition of 3F Fuji Foods Pvt. Ltd.
- Represented SRI Capital (a US-based venture capital fund) in its investments in Indian portfolio companies across enterprise tech, fintech, healthcare, consumer sectors.
- Represented Aurobindo Pharma in its 100% acquisition of a pharmaceutical manufacturing company in the hormonal and oncology specialty segment.